{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:35:08Z","timestamp":1765888508398,"version":"3.44.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013057","name":"Heffter Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jaclp.2020.12.011","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T18:56:41Z","timestamp":1611255401000},"page":"460-471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer"],"prefix":"10.1016","volume":"62","author":[{"given":"Brian S.","family":"Barnett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George R.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaclp.2020.12.011_bib1","first-page":"734","article-title":"Potential therapeutic effects of psilocybin","volume":"14","author":"Johnson","year":"2017","journal-title":"Neurother J Am Soc Exp Neurother"},{"key":"10.1016\/j.jaclp.2020.12.011_bib2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0269881112439253","article-title":"Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials","volume":"26","author":"Krebs","year":"2012","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib3","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archpsyc.1973.01750360040005","article-title":"Residential psychedelic (LSD) therapy for the narcotic addict. A controlled study","volume":"28","author":"Savage","year":"1973","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaclp.2020.12.011_bib4","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJM196512022732302","article-title":"Untoward reactions to lysergic acid diethylamide (LSD) resulting in hospitalization","volume":"273","author":"Frosch","year":"1965","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaclp.2020.12.011_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/NMD.0000000000000828","article-title":"A\u00a0survey of American psychiatrists\u2019 attitudes toward classic hallucinogens","volume":"206","author":"Barnett","year":"2018","journal-title":"J\u00a0Nerv Ment Dis"},{"key":"10.1016\/j.jaclp.2020.12.011_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jaclp.2020.12.011_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.jaclp.2020.12.011_bib11","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","article-title":"MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials","volume":"236","author":"Mithoefer","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"year":"2015","series-title":"A\u00a0manual for MDMA-assisted psychotherapy in the treatment of posttraumatic stress disorder","author":"Mithoefer","key":"10.1016\/j.jaclp.2020.12.011_bib12"},{"year":"2020","series-title":"The Yale manual for psilocybin-assisted therapy of depression (using Acceptance and Commitment Therapy as a therapeutic frame)","author":"Guss","key":"10.1016\/j.jaclp.2020.12.011_bib13"},{"key":"10.1016\/j.jaclp.2020.12.011_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-017-4820-5","article-title":"The hidden therapist: evidence for a central role of music in psychedelic therapy","volume":"235","author":"Kaelen","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jaclp.2020.12.011_bib15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcbs.2019.11.004","article-title":"Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety","volume":"15","author":"Davis","year":"2020","journal-title":"J\u00a0Context Behav Sci"},{"key":"10.1016\/j.jaclp.2020.12.011_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/acps.12904","article-title":"Effects of psilocybin therapy on personality structure","volume":"138","author":"Erritzoe","year":"2018","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jaclp.2020.12.011_bib18","doi-asserted-by":"crossref","first-page":"4853 LP","DOI":"10.1073\/pnas.1518377113","article-title":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","volume":"113","author":"Carhart-Harris","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jaclp.2020.12.011_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnhum.2014.00204","article-title":"The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers","volume":"8","author":"Roseman","year":"2014","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.jaclp.2020.12.011_bib20","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1007\/s00213-017-4684-8","article-title":"Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA)","volume":"234","author":"Young","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jaclp.2020.12.011_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10879-017-9379-2","article-title":"Lommen MJJ: current perspective on MDMA-assisted psychotherapy for posttraumatic stress disorder","volume":"48","author":"Thal","year":"2018","journal-title":"J\u00a0Contemp Psychother"},{"key":"10.1016\/j.jaclp.2020.12.011_bib22","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00213-020-05548-2","article-title":"Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials","volume":"237","author":"Jerome","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jaclp.2020.12.011_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neubiorev.2020.03.017","article-title":"Long-term effects of psychedelic drugs: a systematic review","volume":"113","author":"Aday","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jaclp.2020.12.011_bib24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00005053-196001000-00005","article-title":"Lysergic acid diethylamide: side effects and complications","volume":"130","author":"Cohen","year":"1960","journal-title":"J\u00a0Nerv Ment Dis"},{"key":"10.1016\/j.jaclp.2020.12.011_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/0269881114568039","article-title":"Psychedelics not linked to mental health problems or suicidal behavior: a population study","volume":"29","author":"Johansen","year":"2015","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0269881114565653","article-title":"Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population","volume":"29","author":"Hendricks","year":"2015","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016025","article-title":"Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting","volume":"7","author":"Argento","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaclp.2020.12.011_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.9740\/mhc.2017.01.024","article-title":"Clinical potential of psilocybin as a treatment for mental health conditions","volume":"7","author":"Daniel","year":"2017","journal-title":"Ment Heal Clin"},{"key":"10.1016\/j.jaclp.2020.12.011_bib30","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.biopsych.2005.06.038","article-title":"Psychological and cognitive effects of long-term peyote use among Native Americans","volume":"58","author":"Halpern","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaclp.2020.12.011_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.comppsych.2016.09.003","article-title":"Psychological and neuropsychological assessment of regular hoasca users","volume":"71","author":"Barbosa","year":"2016","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.jaclp.2020.12.011_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.31887\/DCNS.2009.11.3\/egmayfrank","article-title":"Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines","volume":"11","author":"Gouzoulis-Mayfrank","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.jaclp.2020.12.011_bib33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1360-0443.2010.03252.x","article-title":"Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs","volume":"106","author":"Halpern","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.jaclp.2020.12.011_bib34","doi-asserted-by":"crossref","first-page":"e63972","DOI":"10.1371\/journal.pone.0063972","article-title":"Psychedelics and mental health: a population study","volume":"8","author":"Krebs","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaclp.2020.12.011_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci8030047","article-title":"Hallucinogen persisting perception disorder: Etiology, clinical features, and therapeutic perspectives","volume":"8","author":"Martinotti","year":"2018","journal-title":"Brain Sci"},{"key":"10.1016\/j.jaclp.2020.12.011_bib36","first-page":"28","article-title":"Review and Recommendations for drug Testing in substance Use treatment Contexts","volume":"2","author":"Jaffe","year":"2016","journal-title":"J\u00a0Reward Defic Syndr Addict Sci"},{"key":"10.1016\/j.jaclp.2020.12.011_bib37","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1309\/V3J8-3KW2-BPT1-FU15","article-title":"Evaluating hallucinogenic or psychedelic drug intoxication in an Emergency setting","volume":"31","author":"Williams","year":"2000","journal-title":"Lab Med"},{"key":"10.1016\/j.jaclp.2020.12.011_bib38","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1177\/0269881118793086","article-title":"Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016","volume":"32","author":"Leonard","year":"2018","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/01.STR.5.2.213","article-title":"Carotid artery occlusion following ingestion of LSD","volume":"5","author":"Lieberman","year":"1974","journal-title":"Stroke"},{"key":"10.1016\/j.jaclp.2020.12.011_bib40","first-page":"183","article-title":"Coma, hyperthermia and bleeding associated with massive LSD overdose. A report of eight cases","volume":"120","author":"Klock","year":"1974","journal-title":"West J Med"},{"key":"10.1016\/j.jaclp.2020.12.011_bib41","first-page":"2","article-title":"Toxidrome-based Approach to common Poisonings","volume":"3","author":"M\u00e9garbane","year":"2014","journal-title":"Asia Pac J Med Toxicol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib42","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/17512433.2020.1794811","article-title":"Management of overdoses of salvia, kratom, and psilocybin mushrooms\u202f: a literature review","volume":"13","author":"Reinert","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib43","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jemermed.2012.09.096","article-title":"Seizure and transient expressive aphasia in hallucinogenic mushroom (Psilocybe) Poisoning: a case report","volume":"43","author":"De Sagun","year":"2012","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.jaclp.2020.12.011_bib44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00063110-200512000-00011","article-title":"Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after \u201cmagic mushroom\u201d abuse","volume":"12","author":"Bickel","year":"2005","journal-title":"Eur J Emerg Med Off J Eur Soc Emerg Med"},{"key":"10.1016\/j.jaclp.2020.12.011_bib45","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1445-5994.2012.02955.x","article-title":"A\u00a0fatal case of \u201cmagic mushroom\u201d ingestion in a heart transplant recipient","volume":"42","author":"Lim","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/j.jaclp.2020.12.011_bib47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/15563659809162584","article-title":"Psilocybin mushroom (Psilocybe semilanceata) intoxication with myocardial infarction","volume":"36","author":"Borowiak","year":"1998","journal-title":"J\u00a0Toxicol Clin Toxicol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib46","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.ijcard.2007.12.064","article-title":"Apical regional wall motion abnormalities reminiscent to Tako-Tsubo cardiomyopathy following consumption of psychoactive fungi","volume":"134","author":"Nef","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib48","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jvir.2008.05.008","article-title":"Percutaneous transluminal angioplasty in the treatment of extensive LSD-induced lower extremity vasospasm refractory to pharmacologic therapy","volume":"19","author":"Raval","year":"2008","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib49","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2174\/138920110791591490","article-title":"Neurotoxicity of ecstasy (MDMA): an overview","volume":"11","author":"Sarkar","year":"2010","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib50","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/rth2.12360","article-title":"N-Methyl-3,4-methylendioxymethamphetamine (MDMA)-related coagulopathy and rhabdomyolysis: a case series and literature review","volume":"4","author":"Doyle","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jaclp.2020.12.011_bib51","doi-asserted-by":"crossref","first-page":"102630","DOI":"10.1016\/j.drugpo.2019.102630","article-title":"MDMA-related deaths in Australia 2000 to 2018","volume":"76","author":"Roxburgh","year":"2020","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jaclp.2020.12.011_bib52","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/pgmj.57.671.543","article-title":"Clinical toxicology of \u201cmagic mushroom\u201d ingestion","volume":"57","author":"Peden","year":"1981","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jaclp.2020.12.011_bib53","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.1971.03190110067020","article-title":"Extreme hyperthermia after LSD ingestion","volume":"217","author":"Friedman","year":"1971","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.jaclp.2020.12.011_bib54","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/02791072.1998.10399712","article-title":"Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions","volume":"30","author":"Callaway","year":"1998","journal-title":"J\u00a0Psychoactive Drugs"},{"key":"10.1016\/j.jaclp.2020.12.011_bib55","doi-asserted-by":"crossref","first-page":"A2132","DOI":"10.1016\/j.chest.2019.08.2076","article-title":"Prolonged lysergic acid diethylmide induced serotonin syndrome","volume":"156","author":"Singh","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.jaclp.2020.12.011_bib56","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1111\/1556-4029.14214","article-title":"Unexpected serotonin syndrome, epileptic seizures, and Cerebral Edema following 2,5-dimethoxy-4-bromophenethylamine ingestion","volume":"64","author":"Spoelder","year":"2019","journal-title":"J\u00a0Forensic Sci"},{"key":"10.1016\/j.jaclp.2020.12.011_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.23907\/2015.009","article-title":"Fatal 251-NBOMe intoxication: a new recreational risk","volume":"5","author":"Umemura","year":"2015","journal-title":"Acad Forensic Pathol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib58","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnins.2020.00078","article-title":"NBOMes-highly potent and toxic alternatives of LSD","volume":"14","author":"Zawilska","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jaclp.2020.12.011_bib59","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00213-003-1730-5","article-title":"A\u00a0bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities","volume":"173","author":"Schifano","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jaclp.2020.12.011_bib60","article-title":"Environment influencing serotonin syndrome induced by ecstasy abuse","volume":"4","author":"Tao","year":"2017","journal-title":"Ann Forensic Res Anal"},{"key":"10.1016\/j.jaclp.2020.12.011_bib61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bcp.2019.04.013","article-title":"Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use","volume":"164","author":"Luethi","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib62","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/17425255.2020.1749262","article-title":"MDMA interactions with pharmaceuticals and drugs of abuse","volume":"16","author":"Papaseit","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib63","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1007\/s00204-020-02936-7","article-title":"Inhibition and induction of CYP enzymes in humans\u202f: an update","volume":"94","author":"Hakkola","year":"2020","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib64","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/03602532.2019.1638931","article-title":"Metabolism of lysergic acid diethylamide (LSD): an update","volume":"51","author":"Lib\u00e2nio Os\u00f3rio Marta","year":"2019","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jaclp.2020.12.011_bib65","doi-asserted-by":"crossref","first-page":"115","DOI":"10.15288\/jsad.2020.81.115","article-title":"LSD overdoses: three case reports","volume":"81","author":"Haden","year":"2020","journal-title":"J\u00a0Stud Alcohol Drugs"},{"key":"10.1016\/j.jaclp.2020.12.011_bib66","article-title":"Severe neurological sequelae after a recreational dose of LSD","author":"Aaker\u00f8y","year":"2020","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib67","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1176\/ajp.149.6.843b","article-title":"Potential interaction of LSD and fluoxetine","volume":"149","author":"Picker","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaclp.2020.12.011_bib68","article-title":"Intoxication mortelle a la suite de la consommoation volontaire et en groupe de champignons hallucinogenes","volume":"112","author":"Gerault","year":"1996","journal-title":"Bull Soc Mycol Fr"},{"issue":"suppl 4","key":"10.1016\/j.jaclp.2020.12.011_bib69","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1528-1167.2012.03613.x","article-title":"Alcohol and drugs in epilepsy: pathophysiology, presentation, possibilities, and prevention","volume":"53","author":"Leach","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaclp.2020.12.011_bib70","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320912125","article-title":"Psychedelic treatment of functional neurological disorder: a systematic review","volume":"10","author":"Butler","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib71","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib72","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2215-0366(20)30146-2","article-title":"Psychedelic medicine: safety and ethical concerns","volume":"7","author":"Anderson","year":"2020","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.jaclp.2020.12.011_bib73","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fimmu.2015.00358","article-title":"Psychedelics and immunomodulation: novel approaches and therapeutic opportunities","volume":"6","author":"Szabo","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaclp.2020.12.011_bib74","article-title":"Exploratory controlled study of the migraine-Suppressing effects of psilocybin","author":"Schindler","year":"2020","journal-title":"Neurother J Am Soc Exp Neurother"},{"key":"10.1016\/j.jaclp.2020.12.011_bib75","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/02791072.2019.1593559","article-title":"Psychedelic-assisted group therapy: a systematic review","volume":"51","author":"Trope","year":"2019","journal-title":"J\u00a0Psychoactive Drugs"}],"container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296020300148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296020300148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:42:00Z","timestamp":1757407320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667296020300148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2667296020300148"],"URL":"https:\/\/doi.org\/10.1016\/j.jaclp.2020.12.011","relation":{},"ISSN":["2667-2960"],"issn-type":[{"type":"print","value":"2667-2960"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer","name":"articletitle","label":"Article Title"},{"value":"Journal of the Academy of Consultation-Liaison Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaclp.2020.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}